Latest News
Pappas Capital, an investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm’s Specialised Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies. LeVert has a track record of progressing early stage technologies from university research labs to commercialisation, and most recently co-founded two independent innovation labs, Southeast TechInventures (STI) and Ag TechInventures, LLC (AgTI).
“Karen is a highly accomplished entrepreneur, whose significant experience developing early stage companies and meaningful impact on the Research Triangle community will be invaluable as we expand
Graycliff Partners has appointed Ryan Supple as a Principal of the firm. Supple, former Vice President at HKW, will primarily support the deal sourcing function of Graycliff’s private equity business.At HKW, Supple helped manage business development and deal sourcing efforts, including evaluation of acquisition opportunities and coordination of the deal flow process. Prior to joining HKW, Ryan developed and led the deal generation function at HBM Holdings Company. Ryan holds an MBA from The University of Chicago’s Booth School of Business and a finance degree from the University of Kentucky.
“We are fortunate to have Ryan joining the team,”
Turn/River Capital, a technology growth equity and buyout firm, has raised its fourth fund, Turn/River Capital IV (Fund IV). The USD420 million Fund IV was oversubscribed and was completed with a single closing for institutional investors in less than 90 days. With Fund IV, Turn/River Capital currently has over USD700 million in assets under management.
“We are incredibly grateful to our investors for their trust and partnership. The increased commitment from existing investors and strong response from new investors attests to our team and our strategy,” says Dominic Ang, Managing Partner at Turn/River Capital. “It’s been an active year for
Healthcare investment vehicle Impel Healthcare Catalyst (Impel) has announced an additional seven figure investment into its portfolio business Trio Healthcare (Trio).The funding will be used to fast-track the development of Trio’s production facility at its state-of-the-art manufacturing plant in Skipton, Yorkshire, ahead of the anticipated launch of a world’s first product for the ostomy market later this year.
Founded by Lloyd Pearce in 2006, Trio develops, manufactures and distributes a range of novel ostomy products, which have consistently delivered year-on-year growth for the company. Trio has also won two Queens Awards for Enterprise to date, recognised for its contribution
As China sees a surge in new coronavirus cases and the death toll passes 360, Allianz China Insurance and Allianz SE is setting up an emergency response fund to support the country’s fight against the epidemic.
Turn/River Capital, a technology growth equity and buyout firm, has raised its fourth fund, Turn/River Capital IV (Fund IV). The USD420 million Fund IV was oversubscribed and was completed with a single closing for institutional investors in less than 90 days. With Fund IV, Turn/River Capital currently has over USD700 million in assets under management.
“We are incredibly grateful to our investors for their trust and partnership. The increased commitment from existing investors and strong response from new investors attests to our team and our strategy,” says Dominic Ang, Managing Partner at Turn/River Capital. “It’s been an active year for
Riverwood Capital, a private equity firm that invests in high-growth, middle-market companies in the technology, technology-enabled, and other related industries, has promoted Harish Belur, Joaquim Lima, and Scott Ransenberg to Partner.“During the past decade, Harish, Joaquim, and Scott have significantly contributed to building the Riverwood platform, not only as great technology investors but also as experienced operators who have helped our portfolio companies scale their operations,” says Francisco Alvarez-Demalde, Co-Founding Partner and Managing Partner at Riverwood Capital. “These promotions are not only a recognition of their hard work, but also reflect their leadership and ability to continue expanding our franchise.
Trivest Partners (Trivest) has held the final closings of the Trivest Growth Investment Fund II (TGIF II) and the Trivest Discovery Fund with USD435 million and USD235 million of total capital commitments, respectively. Raised concurrently, TGIF II and the Trivest Discovery Fund represent Trivest’s sixth and seventh funds focused exclusively on founder/family-owned investments. Significant support from both Trivest’s existing investor base and select new investors contributed to a streamlined and efficient fundraise. TGIF II and the Trivest Discovery Fund include a diversified mix of limited partners including endowments, corporate and public pensions, insurance companies, funds of funds, family offices and individuals,
Ironwood Capital has exited its debt and minority equity investment in American Residuals Group, the holding company of Denali Water Solutions (Denali), to TPG Growth, a middle market and growth equity platform of alternative asset firm TPG. Denali is a provider of specialty waste and environmental recycling and disposal services in the United States, performing daily organic waste collection, processing, recycling, and disposal for municipal, industrial food processing and downstream industrial customers.
“The Denali management team did an excellent job executing on its investment thesis and growing its network,” says Ironwood Capital Managing Director Dickson Suit. “Denali provides important recycling solutions that contribute to
The day of the UK’s departure from the EU might seem like the end of a long process, but it is now that crucial negotiations on the UK’s future economic relationship with the EU will begin.
Until December 2020, when its transition period will come to an end, the UK will remain a member of the EU customs union and the single market, and the cross-border provision of financial services with the EU will be guaranteed. Meaning that until the end of this year, the UK/Europe split will have no direct regulatory impact.
It’s easy to get caught up in
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm